RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/SHA-384/CBB8ED2623195799206783D45C96129E9487421B70F2CF75CD1781C743C5DF8291135ECDF3496BA80FE9141B19B3029Ehttp://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/CBB8ED2623195799206783D45C96129E9487421B70F2CF75CD1781C743C5DF8291135ECDF3496BA80FE9141B19B3029Ehttp://www.w3.org/2000/01/rdf-schema#comment"targeting of BRM in combination with radiotherapy is supposed to improve the therapeutic outcome of lung cancer patients harboring BRG1 mutations.The present study shows that the moderate radioresponsiveness of NSCLC cells with BRG1 mutations can be increased upon BRM depletion that is associated with a prolonged Rad51-foci prevalence at DNA DSBs."xsd:string
http://purl.uniprot.org/uniprot/#_DA6442E287B40E90AA88DEC70077F18F2556C979B59735B3486539243D3085A172061E6E08A5CE85EEC8EE232702D4D5http://www.w3.org/1999/02/22-rdf-syntax-ns#subjecthttp://purl.uniprot.org/SHA-384/CBB8ED2623195799206783D45C96129E9487421B70F2CF75CD1781C743C5DF8291135ECDF3496BA80FE9141B19B3029E
http://purl.uniprot.org/uniprot/Q56A76http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/CBB8ED2623195799206783D45C96129E9487421B70F2CF75CD1781C743C5DF8291135ECDF3496BA80FE9141B19B3029E
http://purl.uniprot.org/uniprot/#_Q56A76-mappedCitation-30478150http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/CBB8ED2623195799206783D45C96129E9487421B70F2CF75CD1781C743C5DF8291135ECDF3496BA80FE9141B19B3029E